Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

New

Pharmaceutical Drug Delivery Market by Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Topical Drug Delivery, and Others) and Application (Cancer, Diabetes, Respiratory Diseases, Cardiovascular Diseases, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

A06102
Pages: 216
Mar 2020 | 1619 Views
 
Author(s) : Sagar Mukhekar , Onkar Sumant
Tables: 86
Charts: 64
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharmaceutical Drug Delivery Market

Request Now !

The pharmaceutical drug delivery market accounted for $1,200 billion in 2018, and is expected to reach $1,733 billion by 2026, registering a CAGR of 4.7% from 2019 to 2026. 

A pharmaceutical drug delivery (DDS) is a formulation or a device, which is employed for the administration of a therapeutic substance into the body. This system functions by deploying medications to specifically targeted parts of the body by the aid of a medium, which can control the administration of the therapy by the means of either a physiological or chemical trigger. DDS is used to improve the efficacy and safety of an administered drug by controlling the rate, time, and site of release of drug in the body. Moreover, various routes of administration are used to introduce drug delivery system into the body, which include oral drug delivery, pulmonary drug delivery, injectable drug delivery, nasal drug delivery, and others.  

Pharmaceutical Drug Delivery Market

Get more information on this report : Request Sample Pages

The major factor that contributes to the growth of pharmaceutical drug delivery market include surge in awareness related to use of pharmaceutical drug delivery systems. Furthermore, other factors such as rise in healthcare expenditure and surge in governmental support for research in the field of drug delivery fuel the growth of pharmaceutical drug delivery market. In addition, increase in prevalence of various chronic diseases, which require the use of pharmaceutical drug delivery systems is another major factor that contributes to the growth of market. However, rise in number of drug recalls and drug failures restricts the growth of pharmaceutical drug delivery market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period. 

Pharmaceutical Drug Delivery Market Segmentation  

The pharmaceutical drug delivery market size is studied on the basis of route of administration, application, and region to provide a detailed assessment of the market. On the basis of route of administration, it is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, nasal drug delivery, ocular drug delivery, topical drug delivery, and others. By application, it is fragmented into cancer, diabetes, respiratory diseases, cardiovascular diseases, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA). 
 
Segment Review

According to route of administration, the others segment occupied the largest share of pharmaceutical drug delivery market in 2018, and is expected to grow at the fastest pace during the forecast period, owing to rise in awareness related to the use of drug delivery systems and increase in the healthcare expenditure.

Pharmaceutical Drug Delivery Market
By Route of Administration

Your browser does not support the canvas element.

Others is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

By application, the cancer segment occupied the largest share of the pharmaceutical drug delivery market. This growth is attributable to surge in prevalence of cancer. Moreover, rise in need for novel and advanced therapeutics required for cancer treatment is another factor that boots the growth of the market. Furthermore, others segment is expected to grow at the fastest pace during the forecast period, owing to rise in prevalence of various disorders such as respiratory disorders such as asthma and bronchitis. 

Pharmaceutical Drug Delivery Market
By Application

Your browser does not support the canvas element.

Others holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region wise, North America accounted for the major pharmaceutical drug delivery market share in 2018, and is expected to continue this trend, owing to easy availability of pharmaceutical drug delivery systems. Moreover, surge in prevalence of various chronic conditions such as cancer, respiratory diseases, and cardiovascular diseases is another major reason that contributes to the growth of this market. However, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to increase in awareness regarding the use of pharmaceutical drug delivery products. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia, as constant developments lead to surge in awareness related to the use of pharmaceutical drug delivery.

The global pharmaceutical drug delivery market is highly competitive, owing to presence of prominent players in the market. These players have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market are Bayer AG, Becton, Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, 3M Company, Pfizer Inc., and Sanofi.

Pharmaceutical Drug Delivery Market
By Geography

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.1% during 2019-2026.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders:

  • This report entails a detailed quantitative analysis along with the current global pharmaceutical drug delivery market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The pharmaceutical drug delivery market forecast is studied from 2019 to 2026. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key Market Segments:

By Route of Administration

  • Oral Drug Delivery
  • Nasal Drug Delivery 
  • Ocular Drug Delivery 
  • Topical Drug Delivery
  • Others 

By Application

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France 
    • UK 
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Australia 
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description 
1.2. Key market segments

1.2.1. List of key players profiled in the report

1.3. Research methodology

1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Top player positioning

3.2.1. Top investment pockets

3.3. Key forces shaping Pharmaceutical drug delivery industry/market
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of chronic disorders which require the use of drug delivery systems
3.4.1.2. Surge in healthcare expenditure worldwide
3.4.1.3. Rise in number of developments made by key players in drug delivery system market

3.4.2. Restraint

3.4.2.1. Rise in number of drug recalls and drug failures

3.4.3. Opportunity

3.4.3.1. High growth potential in developing economies

3.4.4. Impact Analyses

CHAPTER 4: PHARMACEUTICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Oral drug delivery system

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country

4.3. Nasal drug delivery system

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region

4.3.3. Market analysis by country

4.4. Ocular drug delivery systems

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis by country

4.5. Topical drug delivery system

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis by country

4.6. Other drug delivery system

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis by country

CHAPTER 5: PHARMACEUTICAL DRUG DELIVERY MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Cancer

5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country

5.3. Diabetes

5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country

5.4. Cardiovascular diseases

5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country

5.5. Others

5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country

CHAPTER 6: PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. Market analysis, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. market size and forecast, by route of administration
6.2.2.1.2. U.S. market size and forecast, by application

6.2.2.2. Canada

6.2.2.2.1. Canada market size and forecast, by route of administration
6.2.2.2.2. Canada market size and forecast, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico market size and forecast, by route of administration
6.2.2.3.2. Mexico market size and forecast, by application

6.2.3. North America market size and forecast, by route of administration
6.2.4. North America market size and forecast, by application

6.3. Europe

6.3.1. Key market trends and opportunities
6.3.2. Market analysis, by country

6.3.2.1. Germany

6.3.2.1.1. Germany market size and forecast, by route of administration
6.3.2.1.2. Germany market size and forecast, by application

6.3.2.2. France

6.3.2.2.1. France market size and forecast, by route of administration
6.3.2.2.2. France market size and forecast, by application

6.3.2.3. UK

6.3.2.3.1. UK market size and forecast, by route of administration
6.3.2.3.2. UK market size and forecast, by application

6.3.2.4. Italy

6.3.2.4.1. Italy market size and forecast, by route of administration
6.3.2.4.2. Italy market size and forecast, by application

6.3.2.5. Rest of Europe

6.3.2.5.1. Rest of Europe market size and forecast, by route of administration
6.3.2.5.2. Rest of Europe market size and forecast, by application

6.3.3. Europe market size and forecast, by route of administration
6.3.4. Europe market size and forecast, by application

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities
6.4.2. Market analysis, by country

6.4.2.1. Japan

6.4.2.1.1. Japan market size and forecast, by route of administration
6.4.2.1.2. Japan market size and forecast, by application

6.4.2.2. China

6.4.2.2.1. China market size and forecast, by route of administration
6.4.2.2.2. China market size and forecast, by application

6.4.2.3. India

6.4.2.3.1. India market size and forecast, by route of administration
6.4.2.3.2. India market size and forecast, by application

6.4.2.4. Rest of Asia-Pacific

6.4.2.4.1. Rest of Asia-Pacific market size and forecast, by route of administration
6.4.2.4.2. Rest of Asia-Pacific market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by route of administration
6.4.4. Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. Market analysis, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil market size and forecast, by route of administration
6.5.2.1.2. Brazil market size and forecast, by application

6.5.2.2. South Africa

6.5.2.2.1. South Africa market size and forecast, by route of administration
6.5.2.2.2. South Africa market size and forecast, by application

6.5.2.3. Saudi Arabia

6.5.2.3.1. Saudi Arabia market size and forecast, by route of administration
6.5.2.3.2. Saudi Arabia market size and forecast, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA market size and forecast, by route of administration
6.5.2.4.2. Rest of LAMEA market size and forecast, by application

6.5.3. LAMEA market size and forecast, by route of administration
6.5.4. LAMEA market size and forecast, by application

CHAPTER 7: COMPANY PROFILES

7.1. Bayer AG.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance

7.2. BECTON, DICKINSON AND COMPANY

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. F. Hoffmann-La Roche AG

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. GlaxoSmithKline Plc

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. JOHNSON & JOHNSON

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance

7.6. Merck & Co., Inc.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. Novartis AG

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance

7.8. 3M Company

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Pfizer Inc.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. SANOFI

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.1. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2026 ($MILLION )
TABLE 02. ORAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. NASAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. OCULAR PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. TOPICAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06. OTHERS PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY APPLICATION, 2018-2026 ($MILLION )
TABLE 08. PHARMACEUTICAL DRUG DELIVERY MARKET FOR CANCER, BY REGION, 2018–2026 ($MILLION)
TABLE 09. PHARMACEUTICAL DRUG DELIVERY MARKET FOR DIABETES, BY REGION, 2018–2026 ($MILLION)
TABLE 10. PHARMACEUTICAL DRUG DELIVERY MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 11. PHARMACEUTICAL DRUG DELIVERY MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 12. PHARMACEUTICAL DRUG DELIVERY MARKET, BY REGION, 2018-2026 ($MILLION )
TABLE 13. NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 14. U.S. PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 15. U.S. PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 16. CANADA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 17. CANADA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 18. MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 19. MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 20. NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026($MILLION)
TABLE 21. NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 22. EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 23. GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 24. GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 25. FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 26. FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 27. UK PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 28. UK PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 29. ITALY PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 30. ITALY PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 31. REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 32. REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 33. EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026($MILLION)
TABLE 34. EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 35. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 36. JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 37. JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 38. CHINA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 39. CHINA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 40. INDIA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 41. INDIA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 42. REST OF ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 43. REST OF ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 44. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026($MILLION)
TABLE 45. ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 46. LAMEA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 47. BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 48. BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 49. SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 50. SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 51. SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 52. SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 53. REST OF LAMEA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026 ($MILLION)
TABLE 54. REST OF LAMEA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 55. LAMEA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2019–2026($MILLION)
TABLE 56. LAMEA PHARMACEUTICAL DRUG DELIVERY MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 57. BAYER: COMPANY SNAPSHOT
TABLE 58. BAYER: OPERATING SEGMENTS
TABLE 59. BAYER AG.: PRODUCT PORTFOLIO:
TABLE 60. BD: COMPANY SNAPSHOT
TABLE 61. BECTON, DICKINSON AND COMPANY.: OPERATING SEGMENTS
TABLE 62. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 63. ROCHE: COMPANY SNAPSHOT
TABLE 64. ROCHE: OPERATING SEGMENTS
TABLE 65. ROCHE: PRODUCT PORTFOLIO
TABLE 66. GSK: COMPANY SNAPSHOT
TABLE 67. GSK: OPERATING SEGMENTS
TABLE 68. GSK: PRODUCT PORTFOLIO
TABLE 69. J&J: COMPANY SNAPSHOT
TABLE 70. J&J: OPERATING SEGMENTS
TABLE 71. J&J: PRODUCT PORTFOLIO
TABLE 72. MERCK: COMPANY SNAPSHOT
TABLE 73. 3M: OPERATING SEGMENTS
TABLE 74. MERCK: PRODUCT PORTFOLIO
TABLE 75. NOVARTIS: COMPANY SNAPSHOT
TABLE 76. NOVARTIS: OPERATING SEGMENTS
TABLE 77. NOVARTIS: PRODUCT PORTFOLIO
TABLE 78. 3M: SNAPSHOT
TABLE 79. 3M COMPANY: OPERATING SEGMENTS
TABLE 80. 3M COMPANY: PRODUCT PORTFOLIO
TABLE 81. PFIZER: COMPANY SNAPSHOT
TABLE 82. PFIZER: OPERATING SEGMENTS
TABLE 83. PFIZER: PRODUCT PORTFOLIO
TABLE 84. SANOFI: COMPANY SNAPSHOT
TABLE 85. SANOFI: PRODUCT SEGMENTS
TABLE 86. SANOFI: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. HIGH INTENSITY OF RIVALRY
FIGURE 08. LOW THREAT OF NEW ENTRANT
FIGURE 09. IMPACT ANALYSES, PHARMACEUTICAL DRUG DELIVERY MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF ORAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NASAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF OCULAR PHARMACEUTICAL DRUG DELIVERY MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TOPICAL PHARMACEUTICAL DRUG DELIVERY MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF OTHERS PHARMACEUTICAL DRUG DELIVERY MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL DRUG DELIVERY MARKET FOR CANCER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL DRUG DELIVERY MARKET FOR DIABETES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL DRUG DELIVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL DRUG DELIVERY MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. U.S. PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 20. CANADA PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 21. MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 22. GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 23. FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 24. UK PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 25. ITALY PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 26. REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 27. JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 28. CHINA PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 29. INDIA PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 30. REST OF ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 31. BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 32. SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 33. SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 34. REST OF LAMEA PHARMACEUTICAL DRUG DELIVERY MARKET, 2018-2026 ($MILLION)
FIGURE 35. BAYER: NET SALES, 2016–2018 ($MILLION)
FIGURE 36. BAYER: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 37. BAYER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 38. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. BD: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 40. BD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 41. ROCHE: NET SALES, 2016–2018 ($MILLION)
FIGURE 42. ROCHE: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 43. ROCHE: REVENUE SHARE BY REGION, 2018(%)
FIGURE 44. GSK: NET SALES, 2017–2018 ($MILLION)
FIGURE 45. GSK REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 46. GSK: REVENUE SHARE BY REGIONS, 2018 (%)
FIGURE 47. J&J: NET SALES, 2016–2018 ($MILLION)
FIGURE 48. J&J: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 49. J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 50. MERCK: NET SALES, 2016–2018 ($MILLION)
FIGURE 51. MERCK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 52. MERCK: REVENUE SHARE BY REGION, 2018(%)
FIGURE 53. NOVARTIS AG: NET SALES, 2016–2018 ($MILLION)
FIGURE 54. NOVARTIS AG: REVENUE SHARE BY REGION, 2018(%)
FIGURE 55. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 56. 3M: NET SALES, 2016–2018 ($MILLION)
FIGURE 57. 3M: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 58. 3M: REVENUE SHARE BY REGION, 2018(%)
FIGURE 59. PFIZER: NET SALES, 2016–2018 ($MILLION)
FIGURE 60. PFIZER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 61. PFIZER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 62. SANOFI: NET SALES, 2016–2018 ($MILLION)
FIGURE 63. SANOFI: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 64. SANOFI: REVENUE SHARE BY REGION, 2018 (%)

 
 

A pharmaceutical drug delivery (DDS) is defined as a medium or a carrier, which is used for the administration of drug in the patient’s body. Drugs can be administered into the body through different routes such as oral, pulmonary, and nasal. The utilization of pharmaceutical drug delivery systems has witnessed a significant increase in adoption, owing to surge in prevalence of various chronic conditions such as cardiovascular diseases and cancer. Moreover, rise in governmental support in R&D of these systems and increase in healthcare expenditure boost the growth of the market.

Drugs can be administered into the body through different routes such as oral, pulmonary, and nasal. These routes have their own advantages and disadvantages, which can aid in choosing a suitable route for drug administration. The use of these systems enhances drug targeting specificity, improves drug absorption rates, lowers systemic drug toxicity, and provides protection against biochemical degradation of pharmaceutical agents, which acts as a key driver of the global market.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subscription @ $699 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of pharmaceutical drug delivery market is $1,200 billion in 2018.

A. The forcast period for pharmaceutical drug delivery market is 2019 to 2026

A. The market value of pharmaceutical drug delivery market in 2019 is $1,256.4 billion.

A. The base year is 2018 in pharmaceutical drug delivery market

A. Top companies such as, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc., and Pfizer Inc. held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Other drug delivery systems segment is the most influencing segment owing to surge in prevalence of respiratory conditions across the globe. Furthermore, factors such as rise in awareness related to the use of drug delivery systems and increase in the healthcare expenditure boost the growth of the market.

A. The major factor that fuels the growth of the global pharmaceutical drug delivery market includes surge in prevalence of various chronic conditions such as cardiovascular disorders, diabetes, cancer, and respiratory diseases.

A. Asia-Pacific has the highest growth rate in the market which is growing due to surge in awareness related to use of pharmaceutical drug delivery systems for the treatment of chronic diseases such as diabetes and rheumatoid arthritis.

A. Pharmaceutical drug delivery systems are defined as drug delivery methods which are used for the introduction of therapeutic agents into the body. Furthermore, the administration of these systems is achieved through a suitable route of administration.

A. Pharmaceutical drug delivery systems are employed to achieve high drug targeting specificity, low systemic drug toxicity, and improved drug absorption rates.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Pharmaceutical Drug Delivery Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $0.00
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts